T2 Biosystems
Top Five Articles on 360Dx Last Week: Qiagen, BioMérieux Lawsuit; T2 Biosystems Post-Mortem; More
Last week, readers were most interested in a story about a lawsuit brought forth by Qiagen against BioMérieux in Germany.
The firm laid off all of its employees last month and inked agreements with top executives for part-time consulting work.
Top Five Articles on 360Dx Last Week: New Market for Roche; Caltech Sues Bio-Rad; More
Last week, readers were most interested in a story about Roche entering the STI molecular, POC testing space.
In Brief This Week: T2 Biosystems, Danaher, Agilent, Lucid Diagnostics, More
News items for the week of Feb. 17, 2025.
T2 Biosystems Lays off Employees, Inks Consulting Agreements With Top Execs
Following a delisting decision by the Nasdaq Hearings Panel, the firm laid off its workforce and agreed to pay top executives for part-time consulting work.
Feb 11, 2025
Nasdaq Panel Delisting T2 Biosystems Stock
Dec 13, 2024
T2 Biosystems Receives Delisting Notice From Nasdaq
May 15, 2024